BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 36238309)

  • 1. Exploring the risk factors for ischemic cerebrovascular disease in systemic lupus erythematosus: A single-center case-control study.
    Su L; Qi Z; Guan S; Wei L; Zhao Y
    Front Immunol; 2022; 13():978910. PubMed ID: 36238309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
    Gustafsson JT; Herlitz Lindberg M; Gunnarsson I; Pettersson S; Elvin K; Öhrvik J; Larsson A; Jensen-Urstad K; Svenungsson E
    PLoS One; 2017; 12(4):e0174572. PubMed ID: 28414714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus].
    Fischer K
    Ann Acad Med Stetin; 2008; 54(2):22-32. PubMed ID: 19374227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus.
    Svenungsson E; Gustafsson J; Leonard D; Sandling J; Gunnarsson I; Nordmark G; Jönsen A; Bengtsson AA; Sturfelt G; Rantapää-Dahlqvist S; Elvin K; Sundin U; Garnier S; Simard JF; Sigurdsson S; Padyukov L; Syvänen AC; Rönnblom L
    Ann Rheum Dis; 2010 May; 69(5):834-40. PubMed ID: 19762360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibodies in paediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome.
    Gattorno M; Buoncompagni A; Molinari AC; Barbano GC; Morreale G; Stalla F; Picco P; Mori PG; Pistoia V
    Br J Rheumatol; 1995 Sep; 34(9):873-81. PubMed ID: 7582730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus.
    Fasano S; Pierro L; Pantano I; Iudici M; Valentini G
    J Rheumatol; 2017 Jul; 44(7):1032-1038. PubMed ID: 28507183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
    Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
    Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of osteonecrosis in systemic lupus erythematosus: An 11-year Chinese single-center cohort study.
    Long Y; Zhang S; Zhao J; You H; Zhang L; Li J; Leng X; Wang Q; Tian X; Li M; Zeng X
    Lupus; 2021 Aug; 30(9):1459-1468. PubMed ID: 34082592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
    Groot N; Shaikhani D; Teng YKO; de Leeuw K; Bijl M; Dolhain RJEM; Zirkzee E; Fritsch-Stork R; Bultink IEM; Kamphuis S
    Arthritis Rheumatol; 2019 Feb; 71(2):290-301. PubMed ID: 30152151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-RNP/Sm antibodies in patients with systemic lupus erythematosus and its role in thrombosis: a case-control study.
    Zamora-Medina MDC; Hinojosa-Azaola A; Nuñez-Alvarez CA; Vargas-Ruiz AG; Romero-Diaz J
    Clin Rheumatol; 2019 Mar; 38(3):885-893. PubMed ID: 30515663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematological involvement in pediatric systemic lupus erythematosus: A multi-center study.
    Akca ÜK; Batu ED; Kısaarslan AP; Poyrazoğlu H; Ayaz NA; Sözeri B; Sağ E; Atalay E; Demir S; Karadağ ŞG; Demir F; Bilginer Y; Gümrük F; Özen S
    Lupus; 2021 Oct; 30(12):1983-1990. PubMed ID: 34459313
    [No Abstract]   [Full Text] [Related]  

  • 14. Hydroxychloroquine and Mortality Among Patients With Systemic Lupus Erythematosus in the General Population.
    Jorge A; McCormick N; Lu N; Zheng Y; Esdaile J; De Vera M; Choi H; Aviña-Zubieta JA
    Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1219-1223. PubMed ID: 32407570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus.
    Taraborelli M; Lazzaroni MG; Martinazzi N; Fredi M; Cavazzana I; Franceschini F; Tincani A
    Reumatismo; 2016 Dec; 68(3):137-143. PubMed ID: 27981815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epileptic seizures in systemic lupus erythematosus.
    Appenzeller S; Cendes F; Costallat LT
    Neurology; 2004 Nov; 63(10):1808-12. PubMed ID: 15557494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral arterial disease in patients with systemic lupus erythematosus: a prospective controlled study.
    Hassan AA; Habib HM; Eissa AA
    Int J Rheum Dis; 2013 Jun; 16(3):319-24. PubMed ID: 23981754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events.
    Frerix M; Stegbauer J; Kreuter A; Weiner SM
    Arthritis Res Ther; 2014 Feb; 16(1):R54. PubMed ID: 24548804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.